Guru Ownership Trend
Guru Analysis for Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $32.24 M.
Top institutional holders include Andreas Halvorsen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $25.95 M net inflow during the quarter.
Recent activity highlights Andreas Halvorsen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Artiva Biotherapeutics, Inc. (ARTV)
Major holders include Andreas Halvorsen ($25.26 M), Renaissance Technologies (RenTech) ($1.46 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.76 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $25.95 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ARTV during the most recent reporting period.
Yes, 1 managers opened new positions in ARTV, and 1 increased their existing holdings. The total reported buy value was $25.95 M.